What Is a Heart Scan and When Do You Need One?

A heart scan is a broad term for any imaging test that produces pictures of the heart’s structure, blood vessels, or blood flow without requiring surgery or catheter insertion. The most common versions use computed tomography (CT) to look for calcium buildup in the coronary arteries or to create detailed images of the vessels themselves, but the category also includes cardiac MRI and nuclear perfusion scans. Whether you need one depends on your symptoms, your estimated risk of heart disease, and what question your doctor is trying to answer.

The Main Types of Heart Scans

When people say “heart scan,” they usually mean one of a handful of tests. Each looks at something slightly different, and the one your doctor orders depends on what they suspect.

Invasive coronary angiography, where a catheter is threaded through a blood vessel to inject dye directly into the coronary arteries, remains the gold standard for identifying blockages. But the non-invasive options above have advanced to the point where they can often answer the clinical question without that step.5PubMed Central. Noninvasive cardiac imaging with computed tomography

When You Have Chest Pain or Other Symptoms

The clearest reason to get a heart scan is when you have symptoms that could point to coronary artery disease, such as chest tightness, shortness of breath with exertion, or pain that radiates to the arm or jaw. In these situations, CCTA has emerged as a first-line test for people at low-to-intermediate risk. It has a high negative predictive value, meaning that if the scan comes back clean, you can be quite confident there is no significant coronary disease. It also allows accurate detection of both obstructive and non-obstructive plaque, which helps guide what happens next.6PubMed Central. Chest pain investigation in patients at low or intermediate risk – What is the best first-line test to rule out coronary artery disease?

This “gatekeeper” role matters because the alternative is sending people straight to the catheter lab for an invasive angiogram. A CT scan that convincingly rules out disease can spare you a procedure that carries its own risks, costs more, and requires recovery time. Research supports the idea that cardiac CT can effectively serve as the gatekeeper to invasive angiography, reducing unnecessary catheterizations while still catching the people who genuinely need them.7PubMed Central. CT as gatekeeper of invasive coronary angiography in patients with suspected CAD

When You Have No Symptoms but Worry About Risk

Heart scans for people who feel fine are more nuanced. You can’t scan everyone and expect it to do more good than harm. The 2023 Multimodality Appropriate Use Criteria from the American College of Cardiology lay out specific scenarios where testing asymptomatic people makes sense. Coronary artery calcium scoring is considered appropriate for refining risk in people with borderline or intermediate cardiovascular risk scores. Stress testing with imaging (nuclear, echocardiographic, or MRI-based) is appropriate for people at high risk for silent ischemia. For someone simply wanting to start an unsupervised exercise program who has no known coronary disease, routine imaging is generally not warranted.8American College of Cardiology. 2023 Multimodality Appropriate Use Criteria for Chronic Coronary Disease – Key Points

There are also specific populations the guidelines flag: people who received chest radiation therapy more than five years ago (for instance, certain cancer survivors) may benefit from stress testing or calcium scoring because radiation to the chest area accelerates coronary disease. For these individuals, all stress testing modalities and calcium scoring are considered potentially appropriate.8American College of Cardiology. 2023 Multimodality Appropriate Use Criteria for Chronic Coronary Disease – Key Points

The practical takeaway: if your ten-year risk of a heart attack or stroke puts you squarely in the low or high category, a calcium score probably won’t change your treatment. It’s the in-between group where the scan genuinely helps decide whether to start a statin, ramp up lifestyle changes, or both.

Understanding Your Calcium Score

If you get a coronary calcium scan, the result comes back as an Agatston score. A score of zero means no detectable calcium was found. That is a reassuring finding, though it doesn’t guarantee zero plaque since very early, soft plaque doesn’t contain calcium yet. Scores from 1 to 99 indicate mild buildup; 100 to 399, moderate; and 400 or higher, severe. Scores above 1,000 deserve special attention because they signal a heavy overall plaque burden.

The raw number alone doesn’t tell the whole story. Your score is also compared against what is typical for people of your age, sex, and racial background, generating a percentile. A score of 150 means something different in a 45-year-old man than in a 75-year-old woman. Key elements to pay attention to in a calcium score report include the absolute Agatston score, the age-, sex-, and race-specific percentile, how many vessels have calcium, whether the left main coronary artery is involved, and whether a score above 1,000 is present.9PubMed Central. An Update on Coronary Artery Calcium Interpretation at Chest and Cardiac CT

Doctors also use the score of zero to gauge when a repeat scan might be worthwhile. People who score zero at their first scan generally don’t need another one for several years, because progression from zero tends to be slow. The report should include a recommendation on time-to-rescan.9PubMed Central. An Update on Coronary Artery Calcium Interpretation at Chest and Cardiac CT

Beyond Blockages: What Plaque Imaging Can Reveal

Traditionally, the focus was on whether an artery was narrowed enough to restrict blood flow. But a significant proportion of heart attacks come from plaque that ruptures even though it wasn’t causing a tight blockage. This is why researchers have pushed to characterize plaque, not just measure how much it narrows the artery.

Modern CT scanners with improved spatial resolution can now differentiate between types of plaque. Some plaques are calcified and stable; others are soft, lipid-rich, and more likely to rupture. Identifying these high-risk plaque features is an area of growing interest, because standard risk tools focus on lipid levels and overall risk scores without directly assessing vulnerable plaque.10PubMed Central. High-Risk Coronary Plaque Features: A Narrative Review Newer scoring systems that combine plaque shape, inflammation signals from the fat around the artery, and total plaque burden are being tested to see whether they can better predict who will have a cardiac event.11PubMed Central. Integrated Coronary CT Angiography Assessment of Plaque Vulnerability and Clinical Outcomes – The Morphology-Inflammation-Burden (MIB) Score

This is still evolving, and plaque characterization is not yet a routine part of every CCTA report. But it represents a shift from asking “Is this artery blocked?” to asking “Is this plaque likely to cause trouble?”

CT-Derived Fractional Flow Reserve

One of the more interesting developments is CT-derived fractional flow reserve, or FFR-CT. Fractional flow reserve has long been measured during invasive angiography by threading a pressure wire through a narrowed artery to see whether the blockage actually limits blood flow. FFR-CT does something similar computationally: it takes the images from a standard CCTA and uses fluid dynamics modeling to estimate whether a lesion is restricting flow, without any additional procedure.12PubMed. Diagnostic Accuracy of Computed Tomography-Derived Fractional Flow Reserve – A Systematic Review

Early results are promising. In one study comparing on-site CT-FFR against invasive FFR measurements, per-patient accuracy was about 84%, with 100% sensitivity, meaning it didn’t miss anyone who truly had flow-limiting disease. It also performed better than simply looking at the degree of narrowing on CT images alone, with higher specificity and positive predictive value.13Journal of Cardiovascular Computed Tomography. Diagnostic performance of on-site, CT-derived fractional flow reserve in predicting invasive fractional flow reserve and absolute myocardial blood flow The technology is increasingly being used to help decide whether someone with a moderate-looking blockage on CT actually needs to go to the catheter lab for a stent or can be managed with medication.14PubMed. Comparison of Diagnostic Accuracy of CT Derived Fractional Flow Reserve for Predicting Revascularization

How to Prepare and What the Experience Is Like

A coronary calcium scan is about as simple as imaging gets. You lie on a table, the scanner takes pictures synchronized to your heartbeat, and you’re done in under ten minutes. No needles, no fasting, no special prep.

CCTA requires a bit more. Because the scan needs to capture moving coronary arteries in sharp detail, a slower, steadier heart rate produces much better images. If your resting heart rate is too high, you will likely be given a beta-blocker beforehand to bring it down. This can be an oral dose taken about an hour before or, if more control is needed, an intravenous dose at the time of the scan. Beta-blockers for this purpose are safe for most people, though you’ll be screened for specific conditions like severe asthma or very low blood pressure that would make them inappropriate.15PubMed. Beta-blockers for cardiac CT – a primer for the radiologist16PubMed Central. Beta-blocker administration protocol for prospectively ECG-triggered coronary CT angiography

You’ll also receive an injection of iodinated contrast dye for CCTA. This can cause a brief warm flushing sensation. You’ll be asked to avoid caffeine and sometimes to fast for a few hours beforehand. The actual scan lasts only seconds of breath-holding, though the overall appointment including setup is typically 30 to 60 minutes.

For cardiac MRI, the experience is longer, often 45 to 90 minutes inside the scanner. Nuclear stress tests involve injecting a tracer and then waiting for it to distribute through the heart before imaging, plus a stress portion that can involve either walking on a treadmill or receiving a medication that simulates exercise.

Radiation Exposure and Other Safety Concerns

Any CT-based heart scan involves ionizing radiation, and the dose varies depending on the type of scan and the equipment used. For coronary calcium scoring, the radiation is quite low. A large multi-center study found a mean effective dose of about 1 mSv, with a median of 0.95 mSv, across different scanners and locations.17PubMed Central. Coronary calcium scans and radiation exposure in the multi-ethnic study of atherosclerosis That’s roughly in the range of a mammogram or a couple of chest X-rays. People with very high body mass indexes or those over 75 received somewhat higher doses in that study, but the differences were still modest.

CCTA involves more radiation than a calcium scan because of the contrast-enhanced, higher-resolution protocol, though modern scanners using prospective gating and lower tube settings have brought doses down substantially from earlier generations. Older estimates of calcium scan protocols found a wider range, from under 1 mSv to over 10 mSv, depending heavily on the scanner model and technique used.18Archives of Internal Medicine. Coronary Artery Calcification Screening – Estimated Radiation Dose and Cancer Risk The trend over the past decade has been steadily downward as scanner technology improves.

For CCTA, contrast dye introduces its own set of concerns. Side effects range from mild reactions like itching or nausea to rare but serious allergic responses. The dye can also cause contrast-induced kidney injury, particularly in people who already have impaired kidney function or diabetes. Your kidney function is typically checked with a blood test before contrast is given.19PubMed Central. Side effects of radiographic contrast media – pathogenesis, risk factors, and prevention

Cardiac MRI avoids ionizing radiation entirely but uses gadolinium-based contrast in many protocols, which carries its own rare risks, including a condition called nephrogenic systemic fibrosis in people with severe kidney disease. Nuclear scans involve small amounts of radiation from the tracer, and the total dose depends on the specific isotope used.

Incidental Findings

One underappreciated aspect of heart scans is that the images don’t just show your heart. CT scanners capture a slice of your chest, and radiologists reviewing the images may spot findings in the lungs, bones, or other nearby structures. In one study comparing different cardiac CT protocols, extracardiac findings showed up in about 63% of patients on a wider low-dose chest scan and 7% on a more focused cardiac scan. Among those, about 20% of patients on the wider protocol had findings considered clinically significant, such as lung nodules that needed follow-up or unexpected masses.20PubMed. Incidental extracardiac findings at cardiac CT angiography – comparison of prevalence and clinical significance between precontrast low-dose whole thoracic scan and postcontrast retrospective ECG-gated cardiac scan

This can be a double-edged situation. On one hand, catching an early lung cancer incidentally is clearly beneficial. On the other, finding a small, meaningless nodule can trigger a cascade of follow-up scans, anxiety, and sometimes even unnecessary biopsies. It’s worth knowing going in that your report might mention findings unrelated to your heart, and that many of these turn out to be harmless.

Diagnostic Challenges in Women

Heart disease in women often looks different than it does in men, and this creates specific diagnostic challenges. Women are more likely to have coronary microvascular dysfunction, a condition where the tiny blood vessels in the heart muscle don’t work properly even though the main coronary arteries appear open. Standard tests like stress echocardiography and nuclear perfusion imaging can detect larger-vessel disease in women but are limited in their ability to specifically identify microvascular problems.21PubMed. State of the Art in Noninvasive Imaging of Ischemic Heart Disease and Coronary Microvascular Dysfunction in Women – Indications, Performance, and Limitations

CCTA is developing an emerging role in risk-stratifying women with ischemic symptoms, though it also cannot directly diagnose microvascular dysfunction. PET perfusion imaging can measure absolute blood flow through the heart muscle and comes closer to identifying microvascular disease, but access to PET scanners and the expertise to interpret them is not universal. The result is that women with real cardiac symptoms can sometimes bounce between normal-looking test results and ongoing symptoms, a frustrating pattern that has led to a growing push for specialized cardiac imaging centers with experience in this area.

What a Heart Scan Cannot Tell You

It’s easy to overestimate what a single scan can do. A calcium score tells you about your overall burden of calcified plaque, but it doesn’t reveal whether any particular artery is tight enough to limit blood flow. CCTA shows the anatomy beautifully, but a moderate-looking narrowing on the scan might or might not actually reduce blood flow during exercise, which is why add-on tools like CT-derived FFR exist. A normal stress test tells you that blood supply to the heart muscle is adequate under stress, but it doesn’t rule out non-obstructive plaque that could rupture later.

No single scan answers every question. Your doctor may order one type initially and then a second type to fill in a different piece of the puzzle. This is not a sign of indecision but a reflection of the fact that heart disease has multiple dimensions, including anatomy, blood flow, heart muscle health, and plaque stability, and no test captures all of them in one pass. The growing ability of CCTA to combine anatomical images with plaque characterization and flow estimates is moving toward a more comprehensive single exam, but the technology is not fully there in routine practice yet.